publication venue for
- Mutant p53 exerts its gain of function through activation of the NF-κB pathway 2005
- Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.. 26:127. 2024
- Development and external validation of a breast cancer absolute risk prediction model in Chinese population. 23:62. 2021
- Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study. 20:38. 2018
- Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages. 20:59. 2018
- Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. 19:76. 2017
- Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. 18:110. 2016
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. 18:15. 2016
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. 16:3419. 2014
- Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. 15:R46. 2013
- Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. 14:R42. 2012
- Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells. 7:R661-R668. 2005
- Clinical trial update: National Cancer Institute of Canada. 7:48-51. 2005
- Mutant p53 exerts its gain of function through activation of the NF-κB pathway.. 7:P4.46-P4.46. 2005
- A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. 6:R8-R17. 2004
- S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast. 6:R308-R315. 2004
- Mammographic density is related to stroma and stromal proteoglycan expression. 5:R129-R135. 2003
- Characterising breast tissue for the development of a tissue-equivalent phantom. 2:a43. 2000